ShareJunction - Member Posts

Back

Latest Posts By brchkho1 - Master

About brchkho1

First < Newer 161-180 of 700 Older> Last

13-Jul-2020 15:03

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

Have not learn yet. Some are still licking the wound.

Good Post Bad Post

05-Jul-2020 15:43

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 1

x 0

You may wish to goto his website to register for all future write up to emaill to you. Can view all the past articles in his website too.

zillion ( Date: 05-Jul-2020 15:17) Posted:

Good read, It is most unfortunate that there are just too much governance issue for most of the locally listed companies in SGX. It seems he only covers our local companies and dares not touch any of those overseas that are listed here. The whole of SGX should be taken over/merge with some other international bourses/split into stocks market and derivaties market to get it right.

brchkho1 ( Date: 05-Jul-2020 11:08) Posted:

Please go thru Mak Yuen Teen' s write-up on this Co.
https://governanceforstakeholders.com/2020/07/05/biolidics-disclosures-are-simply-unacceptable/

Good Post Bad Post

05-Jul-2020 14:33

SBS Transit / SBS Transit

Go to Message

x 0

Whatever ths case, transport is an essential service.

Fluffyclouds ( Date: 05-Jul-2020 14:25) Posted:

brother think hold abit longer, after polls and covid recover.

alanllt ( Date: 05-Jul-2020 14:21) Posted:

Thanks. I hoping to hold until $3.50/- if possible.

Good Post Bad Post

05-Jul-2020 12:10

SBS Transit / SBS Transit

Go to Message

x 0

You may also go to SBS Trasnit' s AR 2019 to see the Chairman' s statement.

https://www.sbstransit.com.sg/Uploads/Investor_Relations/Annual_Report/2019/02-07ChairmansStatement.pdf

brchkho1 ( Date: 05-Jul-2020 12:07) Posted:

You may wish to visit this website for better understanding.
SG buses and MRT/LRT are converted to contract models sometime ago.
https://landtransportguru.net/bus/bus-contracting-model/#:~:text=The%20Bus%20Contracting%20Model%20(BCM,public%20bus%20services%20in%20Singapore.& text=With%20the%20Bus%20Service%20Operating,into%20a%20competitive%20tendering%20process.

alanllt ( Date: 05-Jul-2020 11:01) Posted:

I heard from my colleagues that without commuters, they still make money. It is contract rather than fares earn. Is this true ?

Good Post Bad Post

05-Jul-2020 12:07

SBS Transit / SBS Transit

Go to Message

x 0

alanllt ( Date: 05-Jul-2020 11:01) Posted:

I heard from my colleagues that without commuters, they still make money. It is contract rather than fares earn. Is this true ?

Good Post Bad Post

05-Jul-2020 11:59

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

When this Co 1st announced the selling the test kits to US market, I was already sceptical about it. I was not comfortable with the spiking prices and avoided this one and the other one, Clearbridge totally, but monitoring the progress just to see if my concern was correct. My earlier view was, every countries are known to be developing test kits, and the threshold to have a test kits somewhat like face mask, easy to make. What so special about this one? Besides, newer and better ones were being developed by others. Look at the face mask prices, look similiar to the chart of this counter. If this test kit is good, why SG was not using it in the 1st place?

Starship ( Date: 05-Jul-2020 11:49) Posted:

Another YuuZOO in the making?..........................

BIOLIDICS&rsquo DISCLOSURES ARE SIMPLY UNACCEPTABLE
Mak Yuen Teen
Jul 5, 2020

&ldquo Biolidics in a Nutshell&rdquo raising further questions about the value added by Biolidics with respect to the test kits, given that it neither developed nor marketed it &ndash even though my own university, where Biolidics began as a startup, seemed to have misunderstood and mis-stated Biolidics&rsquo role in the development of these test kits. I also questioned the market potential for Biolidics&rsquo test kits in a crowded and rapidly evolving market for similar test kits and other diagnostic tests for Covid-19.

It seems that bad habits are hard to die, especially if regulators are too slow in calling out questionable conduct and initiating investigations. The recent announcement by the company of its termination agreement with Nasdaq-listed Aytu Bioscience is the latest case of questionable disclosure.

On April 23, 2020, Biolidics had announced an &ldquo exclusive distribution&rdquo agreement entered into that same day with Aytu. Under the agreement, Aytu was said to have committed to buy 1.75 million test kits within the first 3 months from Biolidics.

The announcement specifically said: &ldquo Under the terms of the Agreement, Aytu has a binding commitment to purchase from the Company an initial 500,000 COVID-19 Rapid Test Kits within one business day from the date of the Agreement. Aytu is required to purchase from the Company no less than 1,250,000 COVID-19 Rapid Test Kits within the first three months from the date of the Agreement in order to retain exclusivity (the &ldquo Minimum Exclusive Commitment&rdquo ). All third party orders arising from Biolidics&rsquo own referrals and sales will not be included in this Minimum Exclusive Commitment.&rdquo (emphasis mine)

It adds: &ldquo Further, Aytu shall pay for and lead the clinical trials processes, to complete and obtain clearance for the COVID-19 Rapid Test Kits under Section 501(k) of the USA Food, Drug and Cosmetic Act&hellip from the U.S. Food and Drug Administration&hellip .If Aytu completes the Clearance, Aytu shall maintain exclusivity for the remainder of the term of the Agreement&hellip &rdquo (emphasis mine)

It goes on to say: &ldquo The Agreement is likely to contribute positively to the revenue of the Company for the current financial year ending 31 December 2020. However, the Company is unable to quantify the financial impact as there are no minimum purchase quantities beyond the first three months of the Agreement.&rdquo (emphasis mine)

That announcement followed a series of earlier announcements which helped push the price and trading volume of Biolidics up, as shown in the following chart which I posted with my earlier April 26 article.

As I expected, the distribution agreement with Aytu was terminated. This was announced by the company on June 28, more than two months after the earlier announcement. The latest announcement tried to put a positive spin on the bad news by saying that the company has decided to pursue a &ldquo Development Project&rdquo with Aytu instead, and will withdraw the test kits from the US market. No specifics were provided about this so-called &ldquo Development Project&rdquo , the terms of which were said to be in the process of being negotiated and the two companies having said to have signed a &ldquo non-binding letter of intent&rdquo . Given the company&rsquo s past track record of questionable disclosures, investors would be well-advised to disregard this so-called &ldquo Development Project&rdquo .

Biolidics now said that the two parties had mutually agreed to terminate the distribution agreement with effect from June 27, 2020, and to release the claims of the other party of all obligations and duties pursuant to the terms of the termination agreement. It added that under the termination agreement, the company &ldquo is obligated to process a full refund in favour of Aytu for all deposits paid by Aytu with respect to undelivered orders of the COVID-19 Antibody Test Kits&rdquo . The company also intends to voluntarily withdraw its application to the US FDA for the test kits and therefore they will no longer be available in the US.

On July 3, the company responded to a series of questions from SGX regarding the termination of the distribution agreement. The company now disclosed that the company had to date only delivered 13,000 of the test kits to Aytu. Recall that the original announcement on April 23 said Aytu had a binding commitment to purchase 500,000 test kits by April 24.

While SGX&rsquo s questions are pertinent, the company&rsquo s responses do not address the following:

a. Why did the company not announce earlier that it had only delivered 13,000 of the 500,000 test kits, which Aytu was supposed to have acquired by April 24, when the original announcement said that there was a binding commitment for Aytu to buy 500,000 test kits by the next business day?

b. If 1.75 million test kits were expected to be purchased by Aytu by July 23, 2020 to retain exclusivity, and only 13,000 had been delivered by June 28, why did the company not announce this timely? Surely the company did not expect that most of the 1.75 million test kits would be purchased in less than the one month remaining based on the original distribution agreement, especially given how the market for the test kits had continued to become more highly regulated and competitive since the company&rsquo s original announcement?

c. Why did the company agree to give a full refund, including for the 13,000 test kits that had been delivered, given that Aytu had a binding commitment to buy 500,000 test kits? Why is that in the interest of the company?

d. The original announcement also said that Aytu will pay for the clinical trials processes to complete and obtain clearance from the US FDA for the test kits. When did the company become aware that this was not proceeding?

Following the company&rsquo s announcement about the termination agreement on June 26, its share price fell by 22% by the close of the next trading day, on June 29. Trading volume on June 29 was about six times that of the previous trading day. Clearly, the information about the termination is material.

While SGX&rsquo s latest queries and previous queries are good ones, the regulators should conduct a full investigation of possible disclosure breaches, market manipulation and insider trading, starting from the around mid-March. Where there are breaches, those responsible must be held accountable.

The Biolidics case is just the latest blow to the credibility of the market.

brchkho1 ( Date: 05-Jul-2020 11:08) Posted:

Please go thru Mak Yuen Teen' s write-up on this Co.
https://governanceforstakeholders.com/2020/07/05/biolidics-disclosures-are-simply-unacceptable/

Good Post Bad Post

05-Jul-2020 11:08

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

Please go thru Mak Yuen Teen' s write-up on this Co.
https://governanceforstakeholders.com/2020/07/05/biolidics-disclosures-are-simply-unacceptable/

Good Post Bad Post

04-Jul-2020 10:17

Eagle HTrust USD / EAGLE Hosp Reit US$ @$0.780 cents

Go to Message

x 0

Please see Mak Yuen Teen' s article on this counter.
https://governanceforstakeholders.com/2020/07/01/eagle-hospitality-trust-the-one-that-flew-too-far/

Good Post Bad Post

26-Jun-2020 09:01

Dasin Retail Tr / Dasin Retail Trust

Go to Message

x 0

Halt. Pending announcement.

george78 ( Date: 26-May-2020 10:03) Posted:

Probably it' s time to look at this counter which provides exposure to the Guangdong-HK-Macau Greater Bay Area...

Looks like the PRC government is focusing on the Greater Bay Area, just pushed out 26 specific measures to promote trade and investments in the Greater Bay Area.

https://asiatimes.com/2020/05/supportive-measures-unveiled-for-greater-bay-area/

Good Post Bad Post

23-May-2020 12:12

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

Looking at the lists, it appeared to me that the numbers of test kits developed, just like bubble teas in the market, kind of low thresholds to develope.

donnycheh ( Date: 23-May-2020 09:43) Posted:

Okay thanks! Yeah the FDA list is definitely longer.

Cadence88 ( Date: 23-May-2020 00:49) Posted:

Your info is a 3-party one which might not be exhaustive. Better to look at the direct data from FDA. If I read correctly, Bio & Zhejiang Gene biotech's status are the same - "Not FDA Authorized". Look for : Q: What commercial manufacturers are distributing serology test kits under the policy outlined in Section IV.D of the Policy for Coronavirus Disease-2019 Tests? (Updated 5/21) @ https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-testing-sars-cov-2#offeringtests

Good Post Bad Post

23-May-2020 11:31

SIA / SIA

Go to Message

x 0

Oldman278 ( Date: 22-May-2020 19:27) Posted:

The price will go back to 9?? Hoorayy .. Huat ah!!

huatster ( Date: 22-May-2020 18:50) Posted:

Once all the rights are converted to mother shares, STI will be flooded with SIA shares..

Then you know what will happen?

Good Post Bad Post

21-May-2020 10:53

SIA / SIA

Go to Message

x 0

In bigger countries, airlines has a domestic market, we can' t fly from Changi to Tuas. Without other countries allowing entry, I am not too optimistic about near term of next 12 months.

uiop1223 ( Date: 21-May-2020 10:47) Posted:

Take off? Fly from T1 to T5 so that pilots skills not get rusty 🤣 🤣 🤣 😂 😂 😂 🤣 🤣

Timer78 ( Date: 21-May-2020 10:39) Posted:

TERP $4.19. Kateks better cover soon before SQ take off

Good Post Bad Post

21-May-2020 10:48

Sasseur Reit / Sasseur REIT Latest News

Go to Message

x 0

Pandemic will shake out all the weak ones, in China, there are plenty tenants ready to come in to fill up the gap.

laksaman57 ( Date: 15-May-2020 10:39) Posted:

65.4% by gross revenue of lease expiring in 2020 !

Good Post Bad Post

15-May-2020 13:21

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

The way I see, the test kits developed by so many countries, it appeared to be rather easy except the accuracy is the key issue. If everyone can bring up the accuracy over times, the prices of these test kits will be similar to the face masks, drops like a rock when mass production is on.

actan99 ( Date: 15-May-2020 13:10) Posted:

I thought sg govt only currently uses PCR method of testing.
Even mdm sg dowager or whoever professor mak, even seems to imply theses test kits are dubious or will give false negatives ?
Then why now so many test kits in the market now ah ?
Funny man.

Good Post Bad Post

12-May-2020 09:06

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

The Cares Act signed by Trump recently under HR 748 Cares Act was first tabled on 24 Jan 2019, one year ago before the CoVid-19 surfaced in Feb 2020. It' s strange. How this guy, Joe Courtney knew well ahead of time to table such Act? It' s documented in US' Congress.gov website of the time line of thei Act.
https://www.congress.gov/bill/116th-congress/house-bill/748?q=%7B%22search%22%3A%5B%22hr748%22%5D%7D& s=1& r=1

WBdisciple ( Date: 12-May-2020 08:34) Posted:

White House to Distribute $11 Billion in State Test Funding
The Trump administration plans to distribute $11 billion to states for coronavirus testing, according to senior administration officials.

The $11 billion is part of the CARES Act stimulus package. It will be distributed under a formula that reflects the burden of Covid-19 as well as population-based estimates, the officials said. The administration plans to release details about the distribution in the next day or two, the officials said.

The White House is scheduled to hold a news conference later Monday, during which President Donald Trump is expected to announce that states have set May testing goals, and that the federal government is sending materials to help them meet those goals. That includes directly supplying test-kit items like swabs, and by connecting states with manufacturers of other components such as chemical reagents used in the tests.

Shipments of specimen collection supplies were sent out to states starting last week, and each one has received initial shipments, the officials said.

Increased testing is meant to help states reopen businesses, schools and public spaces by giving public health workers tools to identify and track new cases, isolate them and their contacts, and stop the spread of disease. But for weeks state and local health departments have complained of short supplies. Capacity appears to have increased meaningfully over the last month, though states are still working to stand up their infrastructure to implement the strategies.

The officials did not say how many tests states aim to perform in May. The U.S. has performed nearly nine million tests so far, according to the officials.

The federal government has taken an active but at times mixed role in the procurement of supplies to fight the virus. State governors have criticized the federal involvement in acquiring protective gear, ventilators, tests and medicine, saying that federal priorities sometimes overrode state orders or created confusion.

The administration has taken charge, for example, of distributing a new drug from Gilead Sciences Inc. that shows promise in helping infected patients, but some states and doctors have said they were mystified by the process of deciding who got supplies of the drug and who didn&rsquo t.

Good Post Bad Post

08-May-2020 09:55

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

Prof. Mak has been speaking on facts. So far he has been whistle blow many listed companies that went down the drains.

FrancisLim ( Date: 08-May-2020 09:37) Posted:

Prof Mak gave timely warning on Yuzoo, Ayondo amongst many others.

Be careful, DYODD.

Starship ( Date: 08-May-2020 09:30) Posted:

Wow, our Prof Mak has spoken again.
Prof Mak has always been spot on and this time will be no different.

Good Post Bad Post

05-May-2020 21:45

EFH Ltd / BIO PHARMA company do research on MEDICAL DISEASES

Go to Message

x 0

Just like the masks, now $18/50 pcs. Back then was $100/50 pcs. Not too long ago, SS was selling at $36/50 pcs, now is also priced at $18 liao. These test kit believed to be not very high tech stuff, that' s why everyone is producing.

papayaface ( Date: 05-May-2020 21:36) Posted:

With 20 over companies given the go-ahead to develop and produce test kits in Singapore, the market will be flooded with test kits soon. How to make $$$ ? Better follow the BB and bail out immediately. Good luck

Starship ( Date: 05-May-2020 15:56) Posted:

Won' t be surprised if BBs unload to retails yet again by market close.

Good Post Bad Post

04-May-2020 17:27

Sasseur Reit / Sasseur REIT Latest News

Go to Message

x 0

https://links.sgx.com/FileOpen/Sasseur_REIT-PR_Sasseur_Spring_Sales_First_Day_Sales.ashx?App=Announcement& FileID=609173

Good Post Bad Post

29-Apr-2020 19:32

SingHoldings / Sing Holdings - Grossly undervalued

Go to Message

x 0

Better than nothing....

stockinvestor ( Date: 20-Apr-2020 09:41) Posted:

yes but possibly at lower rates.

investshare ( Date: 20-Apr-2020 07:26) Posted:

Means occupancy rate for Apr is 100%?

Good Post Bad Post

27-Apr-2020 09:58

Clearbridge / Medical Stock - Strong Shareholders

Go to Message

x 0

Please see Ms Ho Ching' s comment in her FB yesterday on the test kit:

" Hello, everyone!

There are tests, and there are tests.

While test kits for antibodies may be faster than the swab and PCR approach, they are not meant to test for covid virus itself.

All such antibody test kits should NOT be marketed as covid rapid test kits. That is very misleading.

The presence of an antibody only tells us whether we have had been infected. It is a lag indicator of infection.

And depending on which type of antibody, it tells of the different phases of recovery or infection fighting.

And some antibodies may appear a week after infection, while others appear later.

Or it may also take longer than 2 weeks to mount a response with enough antibodies to be detected.

This can vary from patient to patient.

This is like fever - old folks may mount only a very mild fever to an infection, when a younger person may mount a fever more strongly and clearly.

So antibody test kits may be marketed as antibody test kits, with info on accuracy, sensitivity and specificity. They should not be marketed as rapid covid-19 test kits.

Speed with low accuracy or poor specificity is worse than useless.

What is specificity?

It means the test picks up the antibody to covid-19 specifically, and not the antibody to other human common cold coronaviruses, to dengue, or to other viruses or bacteria.

Otherwise, we may mistake a dengue antibody for a covid antibody for instance. Am exaggerating to make a point, of course, bcos no serious test kit company worth their salt will make such a basic mistake.

What is sensitivity?

This is the ability of the test to pick up low amounts of antibodies or viruses.

For instance, the typical swab and PCR method can take a short or a long time to do - a short time means we multiply the virus bits a few cycles in a RT-PCR and thus have X amount of virus bits that we may not detect, and so this may be useless as a mainstream test kit a long time means we go through many more cycles to generate many more bits of the virus, and thus we can pick up the virus easier, but if we do this for too long, we lower our throughput capacity.

So a test may pick up say 100 viral bits vs another which needs 1000 viral bits, while a 3rd needs just 20 viral bits.

And each will require different time to do so, measured in hours under the RT-PCR approach.

So this is a case of speed vs sensitivity.

This kind of trade off often happens for biological type testing.

There are alternative technologies which may be faster, but none are available in commercial quantiites yet - they are still being developed, or are being validated.

Finally, the accuracy.

This means when we have a reading of Y, we know that the real number could range from Y-Z to Y+Z.

To complicate matters, sometimes we have Y-Z1 to Y+Z2. Hee! But let&rsquo s keep to a single Z for simplicity.

If Z is a small percentage of Y, we know we can rely on the Y to make a decision.

But if Z is bigger than Y, then we pretty much can ignore Y of a certain value.

Take the ATP machine - we use this as a first line check of the amount of living microbial organisms say on a door knob.

Suppose the accuracy Z is 250, and the machine gives a Y reading of 22. That doesn&rsquo t mean that we are really at 22. It means the true number can be anywhere from 0 to 250.

So we should then use the 250 mark as the pass/fail, rather than try to aim to be 0 or 50, etc.

The machine just doesn&rsquo t give us that kind of accuracy to make these low numbers meaningful.

So media reports on all test kits should ask for their test data and share those test data as a way to educate our people fully, and not get carried away by the focus on speed as if that is the be all and end all of test kits. Or ask for their user base.

P.s.
I don&rsquo t have the info on the Biolidics off the top of my head, and have no specific information on their test kit performance.

But it would be good if Biolidics or any other test kit producers share these information with the media.

It is also useful for mainstream media to go get medical or research specialists to help them interpret test kit specs, or go get a tutorial quickly.

Under today&rsquo s emergency situation, many health authorities may give provisional status without requiring the full jing-bang of validation and trials that they would normally require. So waving the names of this or that authority is not the way to go.

And my apologies to both Biolidics and Straits Times for using their story to hang this PSA peg to alert folks on how we should look at news on this or that superduper 2 minute or 10 minute test kit.

Thank you, all, for this opportunity to share some thots and observations.

P.p.s.
A recent NYT article just reported that of the 14 antibody tests, only 3 gave consistently reliable results.

The rest didn&rsquo t perform as advertised.

Layman translation - the rest were junk.

Even the best 3 had flaws.

Only one didn&rsquo t have false positives.

Why does false positives happen?

One reason has to do with specificity as discussed earlier.

If a test cannot be very very specific to covid-19, and recognises something else as covid-19 antibody, we will end up as a false positive. That is a very clear no-no.

Others may have very high false positives - which means they are junk tests.

More on other points in the NYT article later."

newbieliu ( Date: 27-Apr-2020 09:34) Posted:

Those vested all hope to rise today.... but i foresee tomorrow or at least later part of the day . Now it is a bit cloudy.

For now, SG is not using but does not mean other countries would not use it since SG has the time to test the FW slowly to confirm it and in a way " make" the increase in the nmber less scary and spread out over days since it takes many hours to confirm the test result.

Given the fact that no one is 100% confirmed immune to it after recovery from Covid 19, it renders all airlines to request rapid testing to ensure safe flight in time to come as long as no direct cure to this virus is available. Biolidics is definitely not the best company to invest for now since it has been marred by some comments and some negative news on AYTU .

Today should not give in to shortists easily to get your shares at your loss when they cover back..NOT today lol

StevenKan ( Date: 27-Apr-2020 09:26) Posted:

Dun dare to say significantly lar.... but should rise lor...

Good Post Bad Post

First < Newer 161-180 of 700 Older> Last

ShareJunction Version: 27 Nov 2020 ver - All Rights Reserved. Copyright ShareJunction Pte. Ltd. Disclaimer: All prices from are delayed. ShareJunction does not provide you with any financial advice. We are not into the business of providing any investment advice. See our Terms and Conditions and Privacy Policy of using this website. Data is delayed for varying periods of time depending on the exchange, but for at least 15 minutes. Copyright © SIX Financial Information Ltd. and its licensors. All Rights reserved. Further distribution and use by third parties prohibited. SIX Financial Information and its licensors make no warranty for information displayed and accept no liability for data and prices. SIX Financial Information reserves the right to adapt and/or alter this website at any time without prior notice.

Web design by FoundationFlux. Hosted with Signetique Cloud.